Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers.
about
Brain-Derived Neurotrophic Factor and Antidepressive Effect of Electroconvulsive Therapy: Systematic Review and Meta-Analyses of the Preclinical and Clinical LiteratureThe trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contentsA rationally designed agonist antibody fragment that functionally mimics thrombopoietinPreclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist.Considerations in the management of hepatitis C virus-related thrombocytopenia with eltrombopag.The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia.Mathematical model of platelet turnover in thrombocytopenic and nonthrombocytopenic preterm neonatesPlatelet Dynamics in Peritoneal Carcinomatosis Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal OxaliplatinThrombocytopenia in Patients with Chronic Hepatitis C Virus InfectionPopulation Pharmacokinetics and Pharmacodynamics of Benralizumab in Healthy Volunteers and Patients With Asthma.Pharmacodynamics-mediated drug disposition (PDMDD) and precursor pool lifespan model for single dose of romiplostim in healthy subjects.Pharmacodynamic analysis of recombinant human erythropoietin effect on reticulocyte production rate and age distribution in healthy subjectsInterpretation of transit compartments pharmacodynamic models as lifespan based indirect response modelsComparative performance of cell life span and cell transit models for describing erythropoietic drug effectsAbnormal platelet aggregation in idiopathic pulmonary arterial hypertension: role of nitric oxide.The immunogenicity of platelet-derived FVIII in hemophilia A mice with or without preexisting anti-FVIII immunityCircular RNA enrichment in platelets is a signature of transcriptome degradationSemi-mechanistic population pharmacokinetic model of multivalent trastuzumab emtansine in patients with metastatic breast cancer.Basic pharmacodynamic models for agents that alter the lifespan distribution of natural cells.Pharmacodynamic modeling of the effect of changes in the environment on cellular lifespan and cellular response.Modeling time variant distributions of cellular lifespans: increases in circulating reticulocyte lifespans following double phlebotomies in sheep.Lifespan based indirect response models.Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society.Model-Based Discovery and Development of Biopharmaceuticals: A Case Study of Mavrilimumab.Toward the Relevance of Platelet Subpopulations for Transfusion Medicine.Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment.
P2860
Q26777043-C9A23512-C6C3-444F-8A9F-8AE6A98B0CD1Q33364277-6DDC0DF5-3901-4C74-9EC3-C8562FDEDD08Q33372657-4DF0C969-B867-454B-8946-3FB801DC6F29Q33382190-00D3A242-2E04-435A-994B-BC993401A459Q33387808-1BD81BCD-40EC-4D40-937A-A67106AABDA8Q33414386-70298593-3299-4DA3-A040-316FD9CC5984Q33418500-05A7360D-5C4E-4E47-84E9-AE45C27F41D7Q33427607-62F651E9-D033-4636-BB1C-3AE08A70EA17Q33440130-3D5AA1D6-4581-4E38-B8F6-486FFDF9B358Q33581536-6B99B174-D9CA-4333-996B-AB3F692AEEC8Q34293586-4A70BF2B-CA5A-412C-9CE3-B366D617F8B3Q35132886-DD7E524C-B00E-47EF-AE04-1C088F6FCEF0Q35226129-FF6F26C1-5310-40A6-A856-69CD1253C509Q35595803-BDE5FC2B-BF0D-45F6-A51E-5C2A20FE9231Q35850309-1AE43DD9-8C85-4586-BCF1-72A1ED8E8D92Q36675079-0ECD49FA-5BDC-4DC7-8764-6CFF83E07321Q36700678-054CCCCE-0D90-4B3D-A52D-CA6222D84CCCQ37100575-3B8C1902-E377-4B7C-98DE-010E9C5A8BC3Q37170126-B33B0148-7E76-4B94-B333-2B4F9D67FDE2Q37363462-47327F84-9E7B-4961-863D-21EB74EACF29Q37366179-58BA3FEF-C4E5-4000-BA65-5559F0E75BD5Q37972792-6962E0B9-7A9F-4BCD-9093-6740918E2AABQ42935578-3B25D7EC-2AC4-4F1E-B2A8-7A062BD8EB2EQ49447486-A1E19F59-F27D-41D6-8910-5053994245F2Q49828869-1269A025-5045-424B-BB17-372E066A6FD5Q55222537-1B507D9B-8432-4531-8485-B57650981695
P2860
Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Effects of megakaryocyte growt ...... n in healthy human volunteers.
@ast
Effects of megakaryocyte growt ...... n in healthy human volunteers.
@en
type
label
Effects of megakaryocyte growt ...... n in healthy human volunteers.
@ast
Effects of megakaryocyte growt ...... n in healthy human volunteers.
@en
prefLabel
Effects of megakaryocyte growt ...... n in healthy human volunteers.
@ast
Effects of megakaryocyte growt ...... n in healthy human volunteers.
@en
P2093
P1433
P1476
Effects of megakaryocyte growt ...... n in healthy human volunteers.
@en
P2093
Sheridan W
P304
P407
P577
2000-04-01T00:00:00Z